Carmona Martinez, Alfonso <br/><br/>
A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  2014 
 - 1959-68 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.4161/hv.28743  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Child, Preschool<br/>Drug Combinations<br/>Female<br/>Fever--epidemiology<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Incidence<br/>Infant<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--prevention & control<br/>Male<br/>Polysorbates--administration & dosage<br/>Squalene--administration & dosage<br/>Vaccines, Inactivated--administration & dosage<br/>alpha-Tocopherol--administration & dosage